Milestone Pharmaceuticals Inc. (MIST) Misses Q4 EPS by 3c

Milestone Pharmaceuticals Inc. (NASDAQ: MIST) reported Q4 EPS of ($0.19), $0.03 worse than the analyst estimate of ($0.16).

For earnings history and earnings-related data on Milestone Pharmaceuticals Inc. (MIST) click here.

You May Also Be Interested In

• Hegseth: CENTCOM will be busy tonight, U.S. will hit Iran hard
• New Street Research Starts SpaceX (SPCX) at $165 Price Target
• Ashland responds to Ancora Alternatives investor presentation